Here's your one-stop shop for innovation events in Houston this month. Photo via Getty Images

Saddle up, y'all. March might be the city of Houston's busiest month. The Houston Livestock Show and Rodeo has kicked off, as has Houston Tech Rodeo. Plus, Houston innovators have CERAWeek to look forward to, as well as Houston-focused activations in Austin at SXSW. Here's a rundown of what all to throw on your calendar this month.

This article will be updated as more business and tech events are announced.


February 27-March 5 — Houston Tech Rodeo

Houston Exponential returns with its 3rd annual Houston Tech Rodeo, a week of events showcasing and connecting Houston's innovation and tech ecosystem. The majority of the programming is taking place downtown, and all events are free to attend. Click here to browse this year's events upon registration.

Click here for five can't-miss HTR events.

Click here to learn more about HTR.

March 2 — Building a Startup Ecosystem to Support Asian American Entrepreneurs

FilKor Capital's mission is to empower resilient Asian Americans to build enduring companies. We are focused on underserved communities to build deep and systemic impact, starting with Filipino American and Korean Americans. This event will launch a listening tour with a diverse mix of stakeholders (entrepreneurs, funders, government, chambers, corporates, universities, community, etc.) to understand needs, opportunities and ways to engage.

The event is Wednesday, March 2, from noon to 2 pm at Impact Hub Houston (1801 Main St.). Click here to register.

March 2 — Beyond the Pitch Deck

Pitching successfully is more than just creating a deck. Founders get a lot of advice on how to put slides together — but how do investors actually approach the process of determining what companies they want to invest in? In this moderated panel, founders can hear directly from investors to understand their perspectives.

The event is Wednesday, March 2, from 1 to 3 pm at Cannon West Houston (1334 Brittmoore Road). Click here to register.

March 3 — Ignite Healthcare Network’s 5th Annual Fire Pitch Competition 

The Fire Pitch Competition is the culmination of Ignite Healthcare Network's annual accelerator program created to encourage innovation in emerging women-led healthcare companies. The accelerator provides opportunities for women entrepreneurs to engage with advisors, potential customers, and investors to accelerate the growth of their companies.

The event is Thursday, March 3, from 5 to 8:30 pm at Texas Medical Center Innovation (2450 Holcombe Blvd.). Click here to register.

March 4 — 3rd Annual Houston Business Matchmaker

Hosted by the SBA, this annual Business Matchmaking event serves as a powerful means to help small businesses grow by meeting with multiple buyers from large businesses, colleges & universities, local, state, and federal agencies. The optimal outcome is a contract, but at minimum the small business will establish a relationship with an important buyer for future business.

The event is Friday, March 4, from 8:45 am to 3:30 pm, and virtual. Click here to register.

March 7-10 — Agora at CERAWeek

The 40th annual CERAWeek, a week-long event that aims to connect and convene the energy industry, returns to in-person programming this year in downtown Houston. The conference's innovation track, called Agora, has four days of panels, presentations, and networking. Note: InnovationMap has a guide to tapping into Houston innovation at CERAWeek ahead of this year's conference. Click here to read it.

The Agora sessions begin Monday, March 7, and conclude Thursday, March 10. All programming will take place at Hilton Americas-Houston (1600 Lamar St.). Click here to register.

March 8 — Transition on Tap

Transition On Tap is Greentown Labs’ monthly networking event devoted to fostering conversations and connections among the climate and energy transition ecosystem in Houston and beyond, and this one is focused on female founders. Entrepreneurs, investors, students, and friends of climatetech are invited to attend, meet colleagues, discuss solutions, and engage with our growing community.

The event is Tuesday, March 8, at 5 pm at Greentown Houston (4200 San Jacinto St.). Click here to register.

March 10 — Rise to the Top

The Greater Houston Partnership’s Women’s Business Alliance invites you to be part of an energizing conversation featuring outstanding female executives and thought leaders that leave the audience inspired and uplifted at the 11th annual Rise to the Top celebrating International Women's Day. To honor this year's International Women's day theme, #BreakTheBias, a panel of esteemed female leaders will discuss how we can work together to foster diversity, equity and inclusivity in our professional and personal lives. We will also talk mentors and mantras that helped these women rise to the top in their careers.

The event is Thursday, March 10, from 10:30 am to 1:30 pm at Marriott Marquis (1777 Walker St.). Click here to register.

March 10 — MarMo Pitch Competition

The Cannon's MarMo Pitch Competition is a life sciences/biotech-based pitch competition. Five teams will pitch an original tech-centered business idea to a panel of business experts and an audience of entrepreneurs, small business owners, potential investors, students, business and community leaders.

The event is Thursday, March 10, from 4 to 7 pm at The Cannon @ MarMo (2121 Market St.). Click here to register.

March 11-20 — SXSW (in Austin)

After two years of virtual conferences, SXSW is gearing up for in-person programming in Austin this year. The conference traverses film, music, education, and more, including tech and innovation. Plenty of Houston innovators will make the trek west to participate in the activations and networking opportunities. InnovationMap has a guide to tapping into Houston innovation at SXSW ahead of this year's conference. Click here to read it.

SXSW begins Friday, March 11, and conclude Sunday, March 20. All programming will take place in downtown Austin. Click here to register.

March 24 — Future Focus - Sportstech

In partnership with InnovationMap, alliantgroup invites you to an exciting panel discussion on the sportstech industry, where technology is transforming the world of sports. Our conversation will focus on four areas, where multi-billion dollar businesses are emerging seemingly overnight:

  • E-sports
  • Gambling
  • Health/performance
  • Fan engagement

Across these categories, technology is enabling interconnectedness, social interaction, new communities, improved health, subscriber-based business models, software as a service, and new revenue streams.

The event is Thursday, March 24, from 6 to 8 pm at alliantgroup (3009 Post Oak Blvd. Suite 2000.). Click here to register.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.